Trial · NCT00048893
Adverse events131
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 131
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Allergic reaction/hypersensitivity (including drug fever) | Immune system disorders | Carcinoembryonic Antigen (CEA)-Tricom Vaccines | 4 | 37 | 4 |
| other | Allergic rhinitis (including sneezing, nasal stuffiness, postnasal drip) | Immune system disorders | Carcinoembryonic Antigen (CEA)-Tricom Vaccines | 4 | 37 | 4 |
| other | Allergy-Other (Specify, itching & red splotches due to shellfish) | Immune system disorders | Carcinoembryonic Antigen (CEA)-Tricom Vaccines | 1 | 37 | 1 |
| other | Autoimmune reaction | Immune system disorders | Carcinoembryonic Antigen (CEA)-Tricom Vaccines | 1 | 37 | 1 |
| other | Hemoglobin | Blood and lymphatic system disorders | Carcinoembryonic Antigen (CEA)-Tricom Vaccines | 10 | 37 | 172 |
| other | Leukocytes (total WBC) | Blood and lymphatic system disorders | Carcinoembryonic Antigen (CEA)-Tricom Vaccines | 10 | 37 | 169 |
| other | Lymphopenia | Blood and lymphatic system disorders | Carcinoembryonic Antigen (CEA)-Tricom Vaccines | 10 | 37 | 70 |
| other | Neutrophils/granulocytes (ANC/AGC) | Blood and lymphatic system disorders | Carcinoembryonic Antigen (CEA)-Tricom Vaccines | 10 | 37 | 118 |
| other | Neutrophils/granulocytes (ANC/AGC) for BMT studies, if specified in the protocol | Blood and lymphatic system disorders | Carcinoembryonic Antigen (CEA)-Tricom Vaccines | 1 | 37 | 1 |
| other | Platelets | Blood and lymphatic system disorders | Carcinoembryonic Antigen (CEA)-Tricom Vaccines | 10 | 37 | 11 |
| other | Transfusion: Platelets | Blood and lymphatic system disorders | Carcinoembryonic Antigen (CEA)-Tricom Vaccines | 5 | 37 | 11 |
| other | Transfusion: pRBCs | Blood and lymphatic system disorders | Carcinoembryonic Antigen (CEA)-Tricom Vaccines | 7 | 37 | 23 |
| other | Edema | General disorders | Carcinoembryonic Antigen (CEA)-Tricom Vaccines | 3 | 37 | 3 |
| other | Hypotension | General disorders | Carcinoembryonic Antigen (CEA)-Tricom Vaccines | 3 | 37 | 3 |
| other | Phlebitis (superficial) | General disorders | Carcinoembryonic Antigen (CEA)-Tricom Vaccines | 2 | 37 | 2 |
| other | Fibrinogen | Investigations | Carcinoembryonic Antigen (CEA)-Tricom Vaccines | 1 | 37 | 1 |
| other | Partial thromboplastin time (PTT) | Investigations | Carcinoembryonic Antigen (CEA)-Tricom Vaccines | 6 | 37 | 11 |
| other | Prothrombin time (PT) | Investigations | Carcinoembryonic Antigen (CEA)-Tricom Vaccines | 2 | 37 | 3 |
| other | Fatigue (lethargy, malaise, asthenia) | General disorders | Carcinoembryonic Antigen (CEA)-Tricom Vaccines | 8 | 37 | 31 |
| other | Fever (in the absence of neutropenia, where neutropenia is defined as AGC<1.0x10e9/L) | General disorders | Carcinoembryonic Antigen (CEA)-Tricom Vaccines | 7 | 37 | 12 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00048893/events